Innate Pharma(IPHA) - 2023 Q4 - Earnings Call Transcript

Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Results Conference Call March 21, 2024 9:00 AM ET Company Participants Henry Wheeler - Head, Investor Relations Herve Brailly - Interim Chief Executive Officer Sonia Quaratino - Chief Medical Officer Yannis Morel - Chief Operating Officer Frederic Lombard - Chief Financial Officer Arvind Sood - EVP, U.S. Operations Conference Call Participants Daina Graybosch - Leerink Partners Arthur He - H.C. Wainwright Operator At this time, I would like to welcome everyone to the ...